Skip to main content

Jorge E Lascano, MD

Critical Care Specialist

Photo of Jorge E Lascano

Research at a glance

Top areas of exploration

  • alpha 1-Antitrypsin Deficiency , 9 publications
  • Pulmonary Disease, Chronic Obstructive , 8 publications
  • alpha 1-Antitrypsin , 7 publications
  • Phenotype , 3 publications

Research activity

45 publications

540 citations

Why is this important?

Active clinical trials

REACH-OB-23

The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not…

Investigator
Jorge E Lascano
Status
Accepting Candidates
Ages
12 Years - N/A
Sexes
All
Serpentine-1

The Sponsor is developing KB408, a replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-derived vector engineered to deliver functional full-length human SERPINA1 to the airways of people with alpha-1 antitrypsin deficiency…

Investigator
Jorge E Lascano
Status
Accepting Candidates
Ages
18 Years - 70 Years
Sexes
All

My publications

45 publications

2026

Cardiovascular disease-associated admissions in patients with Cystic Fibrosis: A 7-Year U.S. National Inpatient Sample Analysis.

Heart & lung : the journal of critical care

PubMed Publisher's site

2025

Inhaled alpha-1 antitrypsin (AAT) restores lower respiratory tract protease-antiprotease homoeostasis and reduces inflammation in AAT-deficient individuals: a randomised phase 2 study.

ERJ open research

PubMed Publisher's site

2024

Liver Characterization of a Cohort of Alpha-1 Antitrypsin Deficiency Patients with and without Lung Disease.

Journal of clinical and translational hepatology

PubMed Publisher's site

2024

Recombinant Alpha-1 Antitrypsin-Fc Fusion Protein INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency: A Phase 1 Study.

Chronic obstructive pulmonary diseases (Miami, Fla.)

PubMed Publisher's site

2023

Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency.

The American journal of medicine

PubMed Publisher's site